Role of molecular genetics in the clinical management of cholangiocarcinoma

The incidence of cholangiocarcinoma (CCA) has steadily increased during the past 20 years, and mortality is increasing. The majority of patients with CCA have advanced or metastatic disease at diagnosis, and treatment options for unresectable disease are limited, resulting in poor prognosis. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Normanno, N., Martinelli, E., Melisi, D., Pinto, C., Rimassa, L., Santini, D., Scarpa, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198375/
https://www.ncbi.nlm.nih.gov/pubmed/35696744
http://dx.doi.org/10.1016/j.esmoop.2022.100505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198375/
https://www.ncbi.nlm.nih.gov/pubmed/35696744
http://dx.doi.org/10.1016/j.esmoop.2022.100505

Ejemplares similares